|
1
|
Gerber DE, Laccetti AL, Xuan L, Halm EA
and Pruitt SL: Impact of prior cancer on eligibility for lung
cancer clinical trials. J Natl Cancer Inst. 106(pii):
dju3022014.PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lochowski M, Lochowska B, Rebowski M,
Brzezinski D, Cieslik-Wolski B and Kozak J: Five-year survival
analysis and prognostic factors in patients operated on for
non-small cell lung cancer with N2 disease. J Thorac Dis.
10:3180–3186. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stinchcombe TE and Socinski MA: Current
treatments for advanced stage non-small cell lung cancer. Proc Am
Thorac Soc. 6:233–241. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Correction, . New perspectives of curcumin
in cancer prevention. Cancer Prev Res (Phila). 10:3712017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ibrahim S, Tagami T, Kishi T and Ozeki T:
Curcumin marinosomes as promising nano-drug delivery system for
lung cancer. Int J Pharm. 540:40–49. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maran A, Yaszemski MJ, Kohut A and Voronov
A: Curcumin and osteosarcoma: Can invertible polymeric micelles
help? Materials (Basel). 9(pii): E5202016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khan MA, Akhtar N, Sharma V and Pathak K:
Product development studies on sonocrystallized curcumin for the
treatment of gastric cancer. Pharmaceutics. 7:43–63. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ye MX, Li Y, Yin H and Zhang J: Curcumin:
Updated molecular mechanisms and intervention targets in human lung
cancer. Int J Mol Sci. 13:3959–3978. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Du X, Zhang J, Wang J, Lin X and Ding F:
Role of miRNA in lung cancer-potential biomarkers and therapies.
Curr Pharm Des. 23:5997–6010. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lelli D, Pedone C, Majeed M and Sahebkar
A: Curcumin and lung cancer: The role of microRNAs. Curr Pharm Des.
23:3440–3444. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Simental-Mendia LE and Sahebkar A:
Modulation of microRNAs by curcumin in pancreatic cancer. Clin
Nutr. 35:15852016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ye M and Zhang J and Zhang J, Miao Q, Yao
L and Zhang J: Curcumin promotes apoptosis by activating the
p53-miR-192-5p/215-XIAP pathway in non-small cell lung cancer.
Cancer Lett. 357:196–205. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jin H, Qiao F, Wang Y, Xu Y and Shang Y:
Curcumin inhibits cell proliferation and induces apoptosis of human
non-small cell lung cancer cells through the upregulation of
miR-192-5p and suppression of PI3K/Akt signaling pathway. Oncol
Rep. 34:2782–2789. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu Y, Wei C and Xi Z: Curcumin suppresses
proliferation and invasion in non-small cell lung cancer by
modulation of MTA1-mediated Wnt/β-catenin pathway. In Vitro Cell
Dev Biol Anim. 50:840–850. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu JY, Yang X, Chen Y, Jiang Y, Wang SJ,
Li Y, Wang XQ, Meng Y, Zhu MM, Ma X, et al: Curcumin suppresses
lung cancer stem cells via inhibiting wnt/β-catenin and sonic
hedgehog pathways. Phytother Res. 31:680–688. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He M, Li Y, Zhang L, Li L, Shen Y, Lin L,
Zheng W, Chen L, Bian X, Ng HK and Tang L: Curcumin suppresses cell
proliferation through inhibition of the Wnt/β-catenin signaling
pathway in medulloblastoma. Oncol Rep. 32:173–180. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dou H, Shen R, Tao J, Huang L, Shi H, Chen
H, Wang Y and Wang T: Curcumin suppresses the colon cancer
proliferation by inhibiting wnt/β-catenin pathways via miR-130a.
Front Pharmacol. 8:8772017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang JY, Wang X, Wang XJ, Zheng BZ, Wang
Y, Wang X and Liang B: Curcumin inhibits the growth via
Wnt/β-catenin pathway in non-small-cell lung cancer cells. Eur Rev
Med Pharmacol Sci. 22:7492–7499. 2018.PubMed/NCBI
|
|
20
|
Xu JH, Yang HP, Zhou XD, Wang HJ, Gong L
and Tang CL: Role of Wnt inhibitory factor-1 in inhibition of
bisdemethoxycurcumin mediated epithelial-to-mesenchymal transition
in highly metastatic lung cancer 95D cells. Chin Med J (Engl).
128:1376–1383. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang X, Peng Y, Huang Y, Yang M, Yan R,
Zhao Y, Cheng Y, Liu X, Deng S, Feng X, et al: SMG-1 inhibition by
miR-192/-215 causes epithelial-mesenchymal transition in gastric
carcinogenesis via activation of Wnt signaling. Cancer Med.
7:146–156. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen J, Chen Z, Huang J, Chen F, Ye W,
Ding G and Wang X: Bioinformatics identification of dysregulated
microRNAs in triple negative breast cancer based on microRNA
expression profiling. Oncol Lett. 15:3017–3023. 2018.PubMed/NCBI
|
|
23
|
Zhang H, Zhang C, Feng R, Zhang H, Gao M
and Ye L: Investigating the microRNA-mRNA regulatory network in
acute myeloid leukemia. Oncol Lett. 14:3981–3988. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang T, Chen Y, Ge Y, Hu Y, Li M and Jin
Y: Inhalation treatment of primary lung cancer using liposomal
curcumin dry powder inhalers. Acta Pharm Sin B. 8:440–448. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kang HW, Crawford M, Fabbri M, Nuovo G,
Garofalo M, Nana-Sinkam SP and Friedman A: A mathematical model for
microRNA in lung cancer. PLoS One. 8:e536632013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cui J, Mo J, Luo M, Yu Q, Zhou S, Li T,
Zhang Y and Luo W: C-Myc-activated long non-coding RNA H19
downregulates miR-107 and promotes cell cycle progression of
non-small cell lung cancer. Int J Clin Exp Pathol. 8:12400–12409.
2015.PubMed/NCBI
|
|
28
|
Chen Z, Zeng H, Guo Y, Liu P, Pan H, Deng
A and Hu J: MiRNA-145 inhibits non-small cell lung cancer cell
proliferation by targeting c-Myc. J Exp Clin Cancer Res.
29:1512010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park W, Amin AR, Chen ZG and Shin DM: New
perspectives of curcumin in cancer prevention. Cancer Prev Res
(Phila). 6:387–400. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gupta SC, Patchva S and Aggarwal BB:
Therapeutic roles of curcumin: Lessons learned from clinical
trials. AAPS J. 15:195–218. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reuter S, Eifes S, Dicato M, Aggarwal BB
and Diederich M: Modulation of anti-apoptotic and survival pathways
by curcumin as a strategy to induce apoptosis in cancer cells.
Biochem Pharmacol. 76:1340–1351. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Datta R, Halder SK and Zhang B: Role of
TGF-β signaling in curcumin-mediated inhibition of tumorigenicity
of human lung cancer cells. J Cancer Res Clin Oncol. 139:563–572.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang CL, Liu YY, Ma YG, Xue YX, Liu DG,
Ren Y, Liu XB, Li Y and Li Z: Curcumin blocks small cell lung
cancer cells migration, invasion, angiogenesis, cell cycle and
neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One.
7:e379602012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang J, Zhang T, Ti X, Shi J, Wu C, Ren X
and Yin H: Curcumin promotes apoptosis in A549/DDP
multidrug-resistant human lung adenocarcinoma cells through an
miRNA signaling pathway. Biochem Biophys Res Commun. 399:1–6. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang J, Du Y, Wu C, Ren X, Ti X, Shi J,
Zhao F and Yin H: Curcumin promotes apoptosis in human lung
adenocarcinoma cells through miR-186* signaling pathway. Oncol Rep.
24:1217–1223. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhan JW, Jiao DM, Wang Y, Song J, Wu JH,
Wu LJ, Chen QY and Ma SL: Integrated microRNA and gene expression
profiling reveals the crucial miRNAs in curcumin anti-lung cancer
cell invasion. Thorac Cancer. 8:461–470. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiao DM, Yan L, Wang LS, Hu HZ, Tang XL,
Chen J, Wang J, Li Y and Chen QY: Exploration of inhibitory
mechanisms of curcumin in lung cancer metastasis using a
miRNA-transcription factor-target gene network. PLoS One.
12:e01724702017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lu Y, Wang J, Liu L, Yu L, Zhao N, Zhou X
and Lu X: Curcumin increases the sensitivity of
Paclitaxel-resistant NSCLC cells to Paclitaxel through
microRNA-30c-mediated MTA1 reduction. Tumour Biol.
39:10104283176983532017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Suresh R, Ali S, Ahmad A, Philip PA and
Sarkar FH: The role of cancer stem cells in recurrent and
drug-resistant lung cancer. Adv Exp Med Biol. 890:57–74. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang W, Bai W and Zhang W: MiR-21
suppresses the anticancer activities of curcumin by targeting PTEN
gene in human non-small cell lung cancer A549 cells. Clin Transl
Oncol. 16:708–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen S, Gu T, Lu Z, Qiu L, Xiao G, Zhu X,
Li F, Yu H, Li G and Liu H: Roles of MYC-targeting long non-coding
RNA MINCR in cell cycle regulation and apoptosis in non-small cell
lung Cancer. Respir Res. 20:2022019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang J, Jia Y, Zhao S, Zhang X, Wang X,
Han X, Wang Y, Ma M, Shi J and Liu L: BIN1 reverses PD-L1-mediated
immune escape by inactivating the c-MYC and EGFR/MAPK signaling
pathways in non-small cell lung cancer. Oncogene. 36:6235–6243.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chou YT, Lin HH, Lien YC, Wang YH, Hong
CF, Kao YR, Lin SC, Chang YC, Lin SY, Chen SJ, et al: EGFR promotes
lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc
pathway that targets the Ets2 transcriptional repressor ERF. Cancer
Res. 70:8822–8831. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Miao LJ, Huang SF, Sun ZT, Gao ZY, Zhang
RX, Liu Y and Wang J: MiR-449c targets c-Myc and inhibits NSCLC
cell progression. FEBS Lett. 587:1359–1365. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang Y, Cong W, Wu G, Ju X, Li Z, Duan X,
Wang X and Gao H: MiR-376a suppresses the proliferation and
invasion of non-small-cell lung cancer by targeting c-Myc. Cell
Biol Int. 42:25–33. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Krishnamurthy N and Kurzrock R: Targeting
the Wnt/beta-catenin pathway in cancer: Update on effectors and
inhibitors. Cancer Treat Rev. 62:50–60. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Stewart DJ: Wnt signaling pathway in
non-small cell lung cancer. J Natl Cancer Inst. 106:djt3562014.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Shang S, Hua F and Hu ZW: The regulation
of β-catenin activity and function in cancer: Therapeutic
opportunities. Oncotarget. 8:33972–33989. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Park M, Kim M, Hwang D, Park M, Kim WK,
Kim SK, Shin J, Park ES, Kang CM, Paik YK and Kim H:
Characterization of gene expression and activated signaling
pathways in solid-pseudopapillary neoplasm of pancreas. Mod Pathol.
27:580–593. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kang DW, Lee SW, Hwang WC, Lee BH, Choi
YS, Suh YA, Choi KY and Min DS: Phospholipase D1 Acts through
Akt/TopBP1 and RB1 to regulate the E2F1-dependent apoptotic program
in cancer cells. Cancer Res. 77:142–152. 2017. View Article : Google Scholar : PubMed/NCBI
|
